Clinical trials
Withdrawn Phase 2 Neurodegenerative Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2017 | 1 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Andrew Newberg | 1 |
| Inmune Bio, Inc. | 1 |
| Pfizer | 1 |
| Tammie L. S. Benzinger, MD, PhD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neurodegenerative Diseases | 4 |
| Alzheimer Disease | 3 |
| Central Nervous System Diseases | 3 |
| Dementia | 3 |
| Brain Diseases | 2 |
| Cognitive Dysfunction | 2 |
| Tauopathies | 2 |
| Inflammation | 1 |
| Memory Disorders | 1 |
| Mental Disorders | 1 |
Trials
Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.